Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

COPD Risk Confirmed: Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease. Hypertension Warning: A modest increase in high blood pressure ...

Chronic obstructive pulmonary disease (COPD) has seen no new therapies brought to market for around 10 years – and now there have been two in the space of a couple of weeks. The European ...

The health status of patients with chronic obstructive pulmonary disease (COPD) is currently being assessed using several different questionnaires. One of them is the COPD Assessment Test (CAT ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

The study, published in Nicotine & Tobacco Research, confirms the link between e-cigarette use and chronic obstructive pulmonary disease (COPD). This counteracts some claims that e-cigarettes are the ...

Background Previous studies have suggested that long-term use of β agonists to treat chronic obstructive pulmonary disease (COPD) may increase the risk of cardiovascular adverse ... in accordance with ...

For Catholics: As Catholics, we fully participate in the celebration of the Eucharist when we receive Holy Communion. In order to be properly disposed to receive communion, participants should not ...